Generics and Biosimilars Asia 2011 – Moving Forward in the Asian Pharmaceutical Industry

Over the recent years, there has been an intense need for an affordable healthcare system throughout Asia. A strong demand that has been supported by Asian governments, there has been a budding market for biosimilars and generics observed over the recent years. The production and prescription of such drugs have been a well documented trend, driving many companies to explore the untapped generics and biosimilars drug space.

Catering to the health of the citizens and the affordability of such services to the people, the Asian governments have favoured this rising production of prescription drugs, making the Generics and Biosimilars Asia conference one of the highly anticipated gatherings amongst the healthcare professionals.

Addressing the many pressing needs and issues of the generic drug companies, the Generics and Biosimilars Asia 2011 will be bring in innovators and marketers of prescription drug companies, where they will learn more about the many facets that affect and control the industry as a whole. Held on 2nd, 3rd and 4th of March 2011 at Amara Hotel, Singapore, the conference will be the ideal platform for an insightful outlook into the industry.

Recognized as one of the leading drug markets in the world, the generic drug companies have made a huge impact in India and China. Facing problems such as the long term use of multiple uses of drugs, and increasingly aging population and limited purchasing power, the government has been searching within the generic drugs market for high quality medicine and affordable drugs. An attraction for such biotech and pharmaceutical needs, the conference in 2011 will be a one of kind in Asia, a result of extensive research with medical professionals across the continent.

One of the many issues that will be addressed in the 2011 conference is how to overcome the challenges encountered by the biosimilars industry catering to the similar challenges faced in the market today. The experts will also discuss the latest developments of regulations and guidelines for the registration process of biosimilars and generics in Asia and Europe and the key challenges in distributing and marketing the innovate drugs along with the other generic prescriptions. Furthermore, it will present the ideal marketing positions of the products and examine how the strategic alliances will affect innovation and R&D. Attendees will have the opportunity to learn from peers about evaluating the reimbursement policies and how it will affect the drug pricing strategies. They will also be able to network with the experts and discover the pharmacovigilance aspects of biosimilars and generics and safeguarding consumers’ health.

If one is interested in learning more about the evolving pharmaceutical industry in Asia, the Generics and Biosimilar Asia 2011 is a must. If you are searching for a private accommodation Singapore offers, an ideal choice would be Somerset Liang Court. Guests staying in this serviced accommodation Singapore offers will have an exceptional holiday indulging in its finest amenities such as a fitness centre and a Jacuzzi.